DOXORUBICIN-TEVA

Medicinal product

(Invented) name

DOXORUBICIN-TEVA

Active substance (s)

Doksorubicino hidrochloridas

Strength

50 mg

Pharmaceutical form

milteliai injekciniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01DB01, Doxorubicin

Marketing authorisation holder

Teva Pharma B.V., Nyderlandai

Date of authorisation

1998-01-28

Date of renewal

2006-12-14

Documents

0616_1_2 DOXORUBICIN_TEVA milt inj RPP 210303.docx

0616_1_2 Pakuotės lapelis 210303.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Flakone yra	1 vnt.
Doksorubicino hidrochloridas	50 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
16092	4037	1004037	flakonas	N1		Receptinis	LT/1/98/0616/002	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2022-12-29	Išregistruotas
2006-12-14	Perregistruotas
1998-01-28	Registruotas